For more than 35 years, SeerPharma has been a trusted partner to pharmaceutical and medical device organisations across the Asia-Pacific (APAC) region, providing expert guidance on Quality Management Systems (QMS) and Good Manufacturing Practice (GMP) compliance.
At the heart of our work lies a team of highly experienced quality and regulatory...
Life sciences organisations work across diverse countries, languages, and regulations, where accurate communication is vital for compliance and safety. Traditional translation methods are slow and error-prone, creating barriers to global alignment. MasterControl’s AI-powered eQMS removes these challenges by enabling instant translation, clear...
For over 35 years, SeerPharma has been at the forefront of advancing Quality and GMP best practices within the pharmaceutical and medical device sectors. Our clients span the full product lifecycle—from early-stage clinical trials through to international market distribution.
Recurring deviations—especially those involving the same or similar issues—are often red flags for regulatory inspectors. In many cases, significant inspection deficiencies related to inadequate corrective actions could have been prevented if the organisation had recognised the patterns earlier and taken proactive steps.
For most medical device manufacturers, the roadmap to market will start with ISO 13485:2016 certification. Obtaining an ISO 13485:2016 certificate is evidence that the Quality Management System in place is compliant with international standards and is a key component of a registration package with the regulators.
This article was originally published by SeerPharma's business partner MasterControl and is republished in-part here with their permission.
SeerPharma has been a strategic Partner for MasterControl in the Asia-Pacific region for over 5 years. In that time, we've secured business and implemented this solution for over 60 organisations in the Pharmaceutical and Medical device sector, helping them automate business-critical Quality and Manufacturing workflows.
Research and operations of Medical Technology, Biotechnology and Pharmaceutical (MTP) companies aligned with and in some cases certified to Quality Management System (QMS) Standards will ensure Australia is at the forefront of medical innovation.
MTPConnect is a not-for-profit organisation, established by the Australian Federal Government’s Industry Growth Initiative. MTPConnect’s aim is to accelerate the rate of growth of the medical technologies, biotechnologies and pharmaceuticals (MTP) sector to increase commercialisation, collaboration and establish Australia as an Asia-Pacific hub...
How SeerPharma worked closely with a leading Australian manufacturer in Tasmania to automate its material management processes.
Copyright © SeerPharma
